Viral Load Status Before Switching to Dolutegravir-Containing Antiretroviral Therapy and Associations With Human Immunodeficiency Virus Treatment Outcomes in Sub-Saharan Africa

Article

Abstract: Background: Dolutegravir is being rolled out globally as part of preferred antiretroviral therapy (A

Palabras claves:

antiretroviral agents, clinical decision-making, HIV integrase inhibitors, prognosis, Viral load

Autores:

Diero L., Edwards J.K., Kasozi C., Kelvin E.A., Lelo P., Matthew L. Romo, Murenzi G., Musick B.S., Nash D., Odhiambo F., Semeere A.S., Sohn A.H., Urassa M., Wools-Kaloustian K.K., Wyka K.

Fuentes:

scopus